AR122609A1 - COMPOSITIONS AND METHODS FOR THE TREATMENT OF DISEASES AND DISORDERS USING FOURNIERELLA MASSILIENSIS - Google Patents

COMPOSITIONS AND METHODS FOR THE TREATMENT OF DISEASES AND DISORDERS USING FOURNIERELLA MASSILIENSIS

Info

Publication number
AR122609A1
AR122609A1 ARP210101607A ARP210101607A AR122609A1 AR 122609 A1 AR122609 A1 AR 122609A1 AR P210101607 A ARP210101607 A AR P210101607A AR P210101607 A ARP210101607 A AR P210101607A AR 122609 A1 AR122609 A1 AR 122609A1
Authority
AR
Argentina
Prior art keywords
methods
disorders
diseases
compositions
treatment
Prior art date
Application number
ARP210101607A
Other languages
Spanish (es)
Inventor
Alicia Ballok
Loise Francisco-Anderson
Kevin Huynh
Valeria Kravitz
Andrey Mbride
Tyler Rommel
Maria Sizova
Original Assignee
Evelo Biosciences Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Evelo Biosciences Inc filed Critical Evelo Biosciences Inc
Publication of AR122609A1 publication Critical patent/AR122609A1/en

Links

Landscapes

  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)

Abstract

En el presente documento se proporcionan métodos y composiciones farmacéuticas relacionados con las bacterias y las vesículas extracelulares microbianas (VEm) de Fournierella massiliensis, que son útiles como agentes terapéuticos.Provided herein are methods and pharmaceutical compositions related to the bacteria and microbial extracellular vesicles (mEVs) of Fournierella massiliensis, which are useful as therapeutic agents.

ARP210101607A 2020-06-11 2021-06-11 COMPOSITIONS AND METHODS FOR THE TREATMENT OF DISEASES AND DISORDERS USING FOURNIERELLA MASSILIENSIS AR122609A1 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US202063037878P 2020-06-11 2020-06-11

Publications (1)

Publication Number Publication Date
AR122609A1 true AR122609A1 (en) 2022-09-21

Family

ID=83444608

Family Applications (1)

Application Number Title Priority Date Filing Date
ARP210101607A AR122609A1 (en) 2020-06-11 2021-06-11 COMPOSITIONS AND METHODS FOR THE TREATMENT OF DISEASES AND DISORDERS USING FOURNIERELLA MASSILIENSIS

Country Status (1)

Country Link
AR (1) AR122609A1 (en)

Similar Documents

Publication Publication Date Title
CO2022002413A2 (en) Compositions and methods for treating psoriasis and atopic dermatitis using prevotella histicola
CO2021012176A2 (en) Bacterial membrane preparations
AR113011A1 (en) BACTERIAL EXTRACELLULAR VESICULES
CO2020010956A2 (en) Compositions and methods for the treatment of cancer and immune disorders using veillonella bacteria
CO2022000040A2 (en) Processed microbial extracellular vesicles
CO2023000114A2 (en) Compositions and methods for the treatment of diseases and disorders using microbial extracellular vesicles from Oscillospiraceae
ECSP20004580A (en) HUMAN STING SMALL MOLECULE MODULATORS
CO2020007142A2 (en) Compositions and methods for the treatment of immune disorders using strains of lactococcus immunomodulatory bacteria
CL2019002255A1 (en) 2-heteroaryl-3-oxo-2,3-dihydropyridazine-4-carboxamides.
ECSP19076732A (en) FUSED 6–6 BICYCLIC HETEROARYL COMPOUNDS AND THEIR USE AS LATS INHIBITORS
CL2019002135A1 (en) Microbial cells, methods to produce them, and uses for them.
ECSP11011067A (en) COMPOUNDS FOR THE TREATMENT OF DISEASES AND OPHTHALMOLOGICAL DISORDERS
BR112014008759A2 (en) eye disease treatment
UY37379A (en) DERIVATIVES OF N- (PIRIDIN-2-IL) PIRIDINA-SULFONAMIDE AND ITS USE IN THE TREATMENT OF DISEASES
CO2022000659A2 (en) Imidazo[1,2-a]pyridinyl derivatives and their use in the treatment of diseases
CO2023001509A2 (en) Prevotella histicola strain c as oral therapy for inflammatory diseases
CL2009000445A1 (en) Compounds derived from piperidine 1,4 heterocycle substituted, procedure to prepare these compounds, pharmaceutical composition comprising them and their use for pain therapy and the treatment of diseases such as Alzheimer's, schizophrenia, anxiety and depression.
CL2021000033A1 (en) New compounds
BR112022019932A2 (en) COMPOSITIONS FOR METABOLIC HEALTH
ECSP22086300A (en) COMPOSITIONS INCLUDING NANOPARTICLES, METHOD OF PREPARATION AND USES THEREOF
AR071762A1 (en) 5-HYDROXIMETHYL-OXAZOLIDIN-2-ONA DERIVATIVES FOR THE TREATMENT OF BACTERIAL INTESTINAL DISEASES
CO2020014673A2 (en) Selection and use of bacteria that support melatonin to reduce infant colic
AR122609A1 (en) COMPOSITIONS AND METHODS FOR THE TREATMENT OF DISEASES AND DISORDERS USING FOURNIERELLA MASSILIENSIS
AR122608A1 (en) COMPOSITIONS AND METHODS FOR THE TREATMENT OF DISEASES AND DISORDERS USING HARRYFLINTIA ACETISPORA
UY31805A (en) AGONISTS M1, PHARMACEUTICAL COMPOSITIONS OF THE SAME, PROCESSES FOR THEIR PREPARATION AND ITS USES FOR THE TREATMENT OF PAIN